News/Events

  • In-silico human genomics with GeneCards. Stelzer G. et al.

    » more

  • TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway. Martin-Martin N. et al.

    » more

  • Relationship between Magnesium and Clinical Biomarkers on Inhibition of Vascular Calcification. Salem S. et al.

    » more

  • Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. Spoto B. et al.

    » more

SysKid - A Collaborative Research Project to Fight Chronic Kidney Desease

SysKid, a large-scale integrating European research project, aims at understanding chronic kidney disease in the context of diabetes and hypertension. SysKid – which stands for »Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment« – will pave the way for progress in prevention, new diagnostic strategies and treatment options for declining kidney function, which affects millions of patients suffering from diabetes and hypertension.

The project has started on Jan 1, 2010 and is driven by a European Union grant of EUR 11,8 million from Framework Programme 7 (FP 7) and a total project volume of close to EUR 16 million.

The SysKid consortium consists of 26 research groups from 15 countries. Runtime of the project is scheduled for five years.

download the information folder "SysKid- The Future of Renal Research" .

DISSEMINATION

webcast: SME success story in FP7, SYSKID

Learn more about the latest SysKid publications and presentations

» Find out more ...

NEWSLETTER

It is easy to keep up with the latest developments in SysKid: We keep you posted with our Newsletter.

» Read newsletter online

» Download print version

CLOSE UP

Learn more about the SysKid team of the month


» P19-WEIZMANN